Institute for Myeloma and Bone Cancer Research

The Institute for Myeloma and Bone Cancer Research is an independent, non-profit cancer research institute dedicated to finding a cure for multiple myeloma, a plasma cell cancer found in bone marrow. More than 100,000 people are diagnosed with myeloma every year and it is estimated that more than 1,000,000 are living with myeloma worldwide. IMBCR was founded in 2004 by leading myeloma researcher and oncologist, Dr. James R. Berenson whose research in both the clinic and the laboratory has spanned more than 25 years. Research conducted at IMBCR has created many of the novel-therapeutics used for myeloma patients worldwide.

Contact information:

Los Angeles , CA

Programs

Continued Progress in Multiple Myeloma Research: An Update with Dr. James Berenson

Watch Dr. James Berenson’s overview of progress in multiple myeloma research and treatment from ASCO 2014

Published:

Is Treating Myeloma A Marathon or a Sprint?

Dr. James Berenson, from the Institute for Myeloma & Bone Cancer Research, discusses the importance of weighing risks and benefits when choosing a myeloma treatment path.

Published:

ASCO Myeloma Update: More Promising Medicines on the Way

Dr. James Berenson gives his perspective on the latest drug development updates from ASCO 2012

Published:

Understanding Myeloma News About Secondary Cancers and Clotting

Dr. James Berenson helps patients understand new FDA recommendations regarding the use of lenalidomide and an increased risk of secondary cancers.

Published:

Update on the Drug Development Pipeline for Myeloma

Dr. James Berenson covers data presented at the end of 2011 for various agents in trials for myeloma.

Published:

Bone Health Management for Myeloma: More Active Living with Less Worry

Dr. James Berenson provides an update on the prevention and treatment of bone complications due to multiple myeloma

Published:

Showing 9 of 12 programs
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on April 22, 2014